Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05946031 · ClinicalTrials.gov registry record · Early Phase 1

Testing the ETM: Examination and Comparison of Different Methods

A Early Phase 1 study of Cigarette Smoking, sponsored by Virginia Polytechnic Institute and State University.

Completed
Registry status
Early Phase 1
Development phase
87
Enrollment target
1
Study location

NCT05946031 is a Early Phase 1 study of Cigarette Smoking that has completed, run by Virginia Polytechnic Institute and State University. The registered enrollment target is 87 participants, below the 174-participant average among 45 other Cigarette Smoking trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05946031, a Early Phase 1 study of Cigarette Smoking, has completed, sponsored by Virginia Polytechnic Institute and State University.

COMPLETED
Registry status
Early Phase 1
Development phase
87 participants
Enrollment target
1
Study location

Study Summary

This study will experimentally assess the comparability of in-lab and remote procedures with hypothetical and real ETM purchase outcomes.

Conditions Studied

Interventions

  • DRUG Reat ETM
  • DRUG Hypothetical ETM

Study Locations (1)

Virginia

  • Fralin Biomedical Research Institute - Roanoke

Trial Details

FieldValue
Enrollment Target 87 participants
Start Date 2024-07-28
Est. Completion 2025-08-14
Phase Early Phase 1

What the Registry Record Tells You About NCT05946031

The ClinicalTrials.gov registry entry for NCT05946031 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 87 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 174-participant average among 45 other Cigarette Smoking trials with a reported enrollment target (50% lower). The listed sponsor is Virginia Polytechnic Institute and State University, which has 104 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cigarette Smoking appearing as the primary indexed condition, and to 2 interventions - of which Reat ETM is the first listed.

NCT05946031 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT05946031 about?

NCT05946031 is a clinical study titled "Testing the ETM: Examination and Comparison of Different Methods". This study will experimentally assess the comparability of in-lab and remote procedures with hypothetical and real ETM purchase outcomes.

What is the current status of trial NCT05946031?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 87 participants. The study started on 2024-07-28. Estimated completion is 2025-08-14.

What conditions does trial NCT05946031 study?

This clinical trial studies the following conditions: Cigarette Smoking.

What interventions are being tested in trial NCT05946031?

The interventions under investigation include: Reat ETM (DRUG), Hypothetical ETM (DRUG).

Who is sponsoring clinical trial NCT05946031?

This trial is sponsored by Virginia Polytechnic Institute and State University, which has 104 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05946031 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cigarette Smoking

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.